GOLM1 and hepatocellular carcinoma: Moreover, GP73 levels were higher in patients with fibrosis stage ≥ F2 [11.2 (9.8) vs. 7.7 (4.1); P < 0.001] or stage ≥ F3 [13.7 (12.6) vs. 8.1 (4.9); P < 0.001], as well as in cirrhotic [16.2 (15.6) vs. 8.3 (4.5); P < 0.001], decompensated [22.9 (15.9) vs. 14.7 (10.3); P < 0.001], and HCC patients [13.6 (18.5) vs. 10.3 (9); P = 0.017].